Singapore wealthtech platform Keenai partners with Fullerton Fund Management
Fullerton Fund Management will provide the new wealthtech platform with SGD-denominated investment strategies.
Fullerton Fund Management will provide the new wealthtech platform with SGD-denominated investment strategies.

Keenai Gobal on Thursday announced the launch of a new technology platform for the Singapore wealth market to service accredited investors and advisors in a single account.
The new platform, named Keenai Wealth, will offer platform users public markets, private funds, private credit and insurance.
The company said that the new platform aims to offer seamless access to previously fragmented financial solutions. It was formed in partnership with Singapore-headquartered investment firm Lighthouse Canton.
Shilpi Chowdhary, Founder & Group Chief Executive Officer of Lighthouse Canton and Keenai Global explained: “Today, wealthy individuals and their advisers are held back by systems that were never designed to manage a client’s wealth holistically.”
“They neither bring all the information together in one place, nor make the products easily accessible. Keenai Wealth was built to change that by empowering investors to ensure their capital works harder across the entire financial picture.”
As part of the launch, Keenai Wealth partnered with Fullerton Fund Management to offer SGD-denominated investment strategies.
Mark Yuen, Chief Business Development Officer of Fullerton Fund Management, said: “By prioritising SGD-denominated investment strategies, this partnership gives accredited investors a critical tool for asset-liability matching, helping to mitigate foreign currency exposure and optimise portfolio stability.”
“It provides clients with curated access to a suite of high-quality SGD solutions managed by Fullerton.”
The firm also partnered with Airwallex, the Singapore-based fintech for clients of the platform to access cash management solutions, and Poni, for insurance capabilities.
Discounted valuations, improving policy clarity and demographic tailwinds are strengthening the case for healthcare as investors look to diversify away from ever-concentrated technology exposure, according to Yashica Reddy.
The yuan-denominated corporate venture capital (CVC) fund will focus on investments across the artificial intelligence and life sciences ecosystem.
Investors have continued to push positions in tech stocks, emerging markets and North America, while cash hits a new low.